Posted by: Audrey Erbes | March 18, 2012

Learn to Develop Investment Assessment at Berkeley Extension plus Events & Jobs

Upcoming Intensive Berkeley Extension Course, April 19-20, 2012

The life science industry presents very different challenges from those found in other industries and requires specialized knowledge and skills to navigate the unique regulatory path requirements, lengthy development times, expensive clinical trial process, FDA control of advertising and labeling, and impact of managed care on reimbursement and pricing. Despite having an MBA, marketing degree or Ph.D., new employees find they must learn skills to meet these challenges on the job through the “sink or swim” method over several years. There are no company mentors available to train new staff at typical Bay Area biotech companies. I designed this course 10 years ago at UC Berkeley Extension and then revamped it in 2005 to meet the need of professionals who need to accelerate their learning curve to be personally successful as well as support the success of their companies.

The UC Berkeley Extension course “Life Science Business and Marketing: Their Integral Role for Success” offered Thursday and Friday, March 19-20, 2012 in Belmont conveys the foundational research and analysis skills needed on the job to make good marketing and business recommendations as well as decisions across company functions which are involved in the successful commercialization of products. Students learn how to do typical business and marketing assignments common to the workplace and receive templates/outlines for documents.

There are two days of intensive classroom work on the front end and then mentoring by the instructor for balance of term while students complete a term project. Unlike higher priced for-profit out-of-state company classes, these UC Berkeley Extension courses provide hands-on experience from which one will integrate new skills into one’s own repertoire. With this course you can also create ongoing relationships with local instructors who care about your career success going forward and become part of your network.

Course Deliverables

Students will complete a business investment analysis of a company and its technology/products of their choice for the term project completed by end of spring quarter. This work product fits nicely into one’s portfolio to share with hiring managers who are interested in a candidate’s capability to do the business of the open position as well as have a course that counts as elective toward completion of a certificate program.

Included in the course is an extensive student reader with lecture slides for note taking, lists of Internet-accessible information resources I’ve developed over years of work in the industry, templates and samples of projects and gratis access to otherwise paid subscription databases to assist in researching the term project.

See course flyer for further details about instructor and three industry expert guest lecturers. You can register at

Highlights of This Coming Week’s Event Picks

This coming week offers a lot of great meetings but unfortunately there are so many good choices on Thursday the 22nd. Be prepared to make a careful selection. Highlights include:

  • BioCentury TV Today, See new program Webcast Sunday, March 18, 2012, Continuously available starting at 9:00 a.m. EDT; Topic: Is it Enough? Alzheimer’s Action; Speakers: Dr. Richard Hodes, Director of the National Institute on Aging;George Vradenburg, Former AOL Executive and Founder of USAgainstAlzheimer’s and Daniel Perry, CEO of the Alliance for Aging Research
  • Bio2Device Group, Tuesday Morning, March 20, 2012; Topic: “Found in translation: new models for university/industry partnerships;” Speaker: David A. Shaywitz, MD, PhD, Director, Strategic and Commercial Planning, Theravance, Inc.
  • Value & Innovation Free Webinar, Tuesday Morning, March 20, 2012; Topic: “Managing Cancer Costs: The Pathways Experiment;” Speakers: Ira M. Klein, M.D., MBA, FACP, Chief of Staff, Office of the Chief Medical Officer, National Accounts Clinical Sales & Strategy, Aetna, Inc.; Lee Newcomer, SVP, Oncology, Genetics and Women’s; Milayna Subar, M.D., VP, National Practice Leader, Oncology, Medco Health Solutions, Inc.; Health, UnitedHealthcare; Dr. Barry Brooks, Chairman, Pharmacy & Therapeutics Committee, The US Oncology Network; Dr. Arlene Forastiere, Senior Vice President, Medical Affairs; Chair, eviti; Ellen Licking, Senior Editor & Analyst, Real Endpoints, LLC
  • BOLD, Tuesday Late Afternoon, March 20, 2012: Event: Annual Life Science HR Forum: Issues, Trends and Possibilities for the Life Science Industry; Speaker: Hoyoung Huh, M.D., Ph.D. is Chairman of the Board of Geron Corporation
  • BioScience Forum, Wednesday Evening, March 21, 2012; Topic: “Controlling Antibiotic-Resistant Infections with Phage Therapy: Development of the Therapy and its Enabling Intellectual Property through Scientific Inquiry;” Speaker: Janakiraman Ramachandran, Ph.D., Chairman and CEO, GangaGen Inc
  • Engineering in Medicine and Biology Society (EMBS), Wednesday Evening, March 21, 2012; Topic: Decentralization of Care: The Circle of Enabling Technologies; Speaker: Gregory T. A. Kovacs, M.D., Ph.D., Stanford University
  • PDA West Coast Chapter 2012, Thursday Evening, March 22, 2012 ; Event: “Professional Dinner Meeting Series: ICH Quality Guideline Q11, Development and Manufacturing of APIs – An Update from the Trenches;” Speaker: Steven R. Mendivil, Executive Director, International Quality, External Affairs, Amgen, Inc.
  • San Francisco Women in Bio, Thursday Evening, March 22, 2012; Event: Launch Networking Meeting; Event Speakers: Kim Popovits, CEO Genomic Health; Phyllis Dillinger, President, WIB
  • HBA San Francisco Bay Area, Thursday Evening, March 22, 2012; Topic: “Building Your Career Through Planned Networking;” Speakers: Kristin Austin, Panelist, Director, Scientific Partnerships, Onyx Pharmaceuticals; Connie Hampton, Panelist, Principal, Hampton Associates, Executive & Scientific Search; Marge Josephson, Panelist, Vice President, Human Resources and Operational Services, Bay City Capital; Carol Wells, Speaker and Panel Moderator, Senior Director Commercial Training & Development, Genentech
  • East Bay AWIS March Chapter Meeting, Thursday Evening, March 22, 2012; Topic: “Inhibition of tumor invasiveness and metastasis by combined c-Met and VEGF blockade;” Speaker: Barbara Sennino, PhD, Cancer and Vascular Biologist, UCSF

See full list of meetings through May in Audrey’s Picks and this week’s new positions listings in Jobs That Crossed My Desk through March 18th by right clicking on the highlighted titles.

I’ll be at the Bio2Device Group meeting and Bioscience Forum but out of town on the March 22nd so didn’t have to make decision which event to attend!


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s


%d bloggers like this: